ArticleThe oncologist2018

Tumor Molecular Testing Guides Anti-PD-1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair Variants.

Shyam A Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.